Dexamethasone, or MK-125, is a corticosteroid fluorinated at position 9 used to treat endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions. Developed in 1957, it is structurally similar to other corticosteroids like hydrocortisone and prednisolone.
Dexamethasone was granted FDA approval on 30 October 1958. In a press release for the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial on 16 June 2020, dexamethasone was recommended for use in COVID-19 patients with severe respiratory symptoms. Dexamethasone reduced deaths by approximately one third in patients requiring ventilation and by one fifth in those requiring oxygen.
Dexamethasone and ciprofloxacin otic suspension is indicated for bacterial infections with inflammation in acute otitis media and acute otitis externa. Intramuscular and intravenous injections are indicated for a number of endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions. Oral tablets are indicated for the treatment of multiple myeloma. An intravitreal implant is indicated for some forms of macular edema and non-infectious posterior uveitis affecting the posterior of the eye. Various ophthalmic formulations are indicated for inflammatory conditions of the eye.
Mayo Clinic Cancer Center, Rochester, Minnesota, United States
Mayo Clinic Scottsdale, Scottsdale, Arizona, United States
M D Anderson Cancer Center, Houston, Texas, United States
Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway
Department of Ophthalmology, St Olavs University Hospital, Trondheim, Norway
Ohio State University Medical Center, Columbus, Ohio, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Children's Hospital of Boston, Boston, Massachusetts, United States
MBCCOP - Gulf Coast, Mobile, Alabama, United States
CCOP - Central Illinois, Decatur, Illinois, United States
CCOP - Kalamazoo, Kalamazoo, Michigan, United States
Washington County Hospital, The Center for Clinical Research, Hagerstown, Maryland, United States
Oncology & Hematology Specialists, PA, Denville, New Jersey, United States
Hackensack University Medical Center, Hackensack, New Jersey, United States
St Antonius Hosptial, Nieuwegein, Utrecht, Netherlands
Gelderse Vallei Ede, Ede, Gelderland, Netherlands
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.